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Abstract  22 
Staphylococcus aureus is a serious human and animal pathogen threat exhibiting extraordinary 23 
capacity for acquiring new antibiotic resistance traits in the pathogen population worldwide.  24 
The development of fast, affordable and effective diagnostic solutions capable of discriminating 25 
between antibiotic-resistant and susceptible S. aureus strains would be of huge benefit for effective 26 
disease detection and treatment. Here we develop a diagnostics solution that uses Matrix-Assisted 27 
Laser Desorption/Ionisation – Time of Flight Mass Spectrometry (MALDI-TOF) and machine 28 
learning, to identify signature profiles of antibiotic resistance to either multidrug or benzylpenicillin in 29 
S. aureus isolates. Using ten different supervised learning techniques, we have analysed a set of 82 S. 30 
aureus isolates collected from 67 cows diagnosed with bovine mastitis across 24 farms. For the 31 
multidrug phenotyping analysis, LDA, linear SVM, RBF SVM, logistic regression, naïve Bayes, MLP 32 
neural network and QDA had Cohen’s kappa values over 85.00%. For the benzylpenicillin 33 
phenotyping analysis, RBF SVM, MLP neural network, naïve Bayes, logistic regression, linear SVM, 34 
QDA, LDA, and random forests had Cohen’s kappa values over 85.00%. For the benzylpenicillin the 35 
diagnostic systems achieved up to (mean result ± standard deviation over 30 runs on the test set) : 36 
accuracy = 97.54% ± 1.91%, sensitivity = 99.93% ± 0.25%, specificity = 95.04% ± 3.83%, and 37 
Cohen’s kappa = 95.04% ± 3.83%.  38 
Moreover, the diagnostic platform complemented by a protein-protein network and 3D structural 39 
protein information framework allowed the identification of five molecular determinants underlying 40 
the susceptible and resistant profiles. Four proteins were able to classify multidrug-resistant and 41 
susceptible strains with 96.81% ± 0.43% accuracy. Five proteins, including the previous four, were 42 
able to classify benzylpenicillin resistant and susceptible strains with 97.54% ± 1.91% accuracy.  43 
Our approach may open up new avenues for the development of a fast, affordable and effective day-44 
to-day diagnostic solution, which would offer new opportunities for targeting resistant bacteria. 45 
 46 
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Author Summary 47 
Antibiotic resistance is one of the biggest threats to human and animal health. The incessant 48 
emergence of new multidrug-resistant bacteria needs to be counterbalanced by the implementation of 49 
effective diagnostics solutions to detect resistance and support treatment selection.  50 
The objective of this study is the development of effective diagnostic solutions to identify resistance 51 
to benzylpenicillin and other drugs in S. aureus strains infecting dairy cattle. S. aureus is one of the 52 
most common pathogens of clinical mastitis in the dairy industry, affecting productivity, profitability, 53 
animal health and welfare, and has an extraordinary capacity for acquiring new antibiotic resistance 54 
traits.  55 
Our diagnostic solution combines machine learning and mass spectrometry. The application to a test 56 
set of 82 S. aureus isolates collected from 67 cows diagnosed with bovine mastitis across 24 farms 57 
discriminated between multidrug-resistant and susceptible strains with (mean result ± standard 58 
deviation over 30 runs on the test set) 96.81% ±0.43% accuracy, and between benzylpenicillin-59 
resistant and susceptible strains with 97.54% ± 1.91% accuracy. Through a dedicated bioinformatics 60 
pipeline developed on the results of machine learning, we were able to obtain new insights into the 61 
molecular determinants and mechanism underlying the antibiotic resistance phenotypes. We believe 62 
that our approach may open up new avenues for the development of a fast, affordable and effective 63 
diagnostic solution which would offer new opportunities for targeting resistant bacteria and support 64 
with timely, accurate and targeted treatment selection.  65 
 66 
Introduction 67 
Staphylococcus aureus is a major opportunistic pathogen, infecting both humans and a wide variety of 68 
animals including dairy cattle, which have been recently proven to pose an important zoonotic 69 
potential, being the principal animal reservoir of novel human epidemic clones [1]. Worldwide, S. 70 
aureus is one of the most frequently isolated pathogens of bovine mastitis, which remains a 71 
significant problem in the dairy industry by affecting productivity, profitability, animal health and 72 
welfare [2]. The majority of bovine mastitis infections caused by S. aureus exhibit subclinical and 73 
chronic manifestations resulting in long-term intramammary persistence [3]. S. aureus can reproduce 74 
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swiftly upon entering the mammary gland and induce immune reactions that can lead to tissue injuries 75 
[4]. Most of the time, the immune response of the cow itself cannot successfully eliminate the S. 76 
aureus infection and treatment is needed [4]. Existing S. aureus vaccines are not considered as a 77 
preventive solution due to their yet unproven effectiveness against infections [5]. 78 
In 2000, Gentillini et al. [6] indicated that beta-lactams (penicillins and cephalosporins), 79 
aminoglycosides, macrolides and lincosamides were the most commonly used antibiotics for 80 
treatment of bovine mastitis. In addition, according to a recent survey [7] in 2018, penicillins, 81 
aminoglycosides and third/fourth generation cephalosporins were the most common antibiotics used 82 
on the treatment for bovine mastitis in the UK. The first examples of using benzylpenicillin for bovine 83 
mastitis treatment can be traced back to the 1940s [8]. However, penicillin-resistant S. aureus strains, 84 
carrying a penicillinase/beta-lactamase emerged shortly after its first clinical usage and by the early 85 
1950s, they became pandemic [8]. In 1959 a penicillin derivative, methicillin, that was resistant to β-86 
lactamase hydrolysis was synthetized. However, immediately after methicillin was used clinically, 87 
methicillin-resistant S. aureus (MRSA) strains were isolated [9, 10]. Resistance to methicillin is 88 
conferred by the acquisition of a mobile genetic element, the staphylococcal cassette chromosome 89 
(SCCmec) carrying the gene mecA encoding a penicillin-binding protein (PBP2a) [9, 10]. Over the 90 
years, mutations, acquisition and accumulation of antibiotic resistance-conferring genes, divergent 91 
mecA gene homologues (mecC) [11, 12] and SCCmec elements [11] have led to the emergence of 92 
multi-resistant MRSA strains [13].  93 
Nowadays, MRSA are resistant to virtually all β-lactam antibiotics [11]. Since its emergence in the 94 
early 2000’s, livestock-associated methicillin-resistant S. aureus (LA-MRSA) has become an 95 
emerging problem in many parts of the world [14-16]. The detection of mecC MRSA from dairy 96 
cattle in England [12] was reported in 2011. The first isolation of both mecA and mecC LA-MRSA. In 97 
bulk milk from dairy cattle in the UK was reported in 2012 [17]. Worryingly, a number of studies 98 
have suggested possible human-livestock MRSA transmissions [16, 18-20]. In addition, several 99 
studies have reported that persons with occupational livestock exposure may be at increased risk of 100 
becoming colonized with LA-MRSA [21]. More than 90% of current human-associated isolates [22] 101 
and varying from 84% to 92% of dairy-related isolates were observed to be penicillin-resistant [23, 102 
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24]. However, the UK surveillance report between 2016 and 2018 showed that penicillin resistance in 103 
S. aureus was relatively low (20.4% on average) in British dairy cattle [25].  104 
It is not uncommon in dairy cattle practice to give antibiotics to healthy animals to prevent the 105 
insurgence of diseases, and to sick animals often without certainty about the actual bacterial origin of 106 
the disease. Even when the disease is of recognised bacterial origin, broad-spectrum antibiotics are 107 
often used, instead of targeting the specific bacterial strain causing the illness. Underlying such 108 
prescription practices is the lack of fast, affordable and effective diagnostic solutions, which leaves 109 
the veterinarian to primarily rely on educated guesses. These practices have serious consequences, 110 
amongst which is the appearance and diffusion of multidrug antibiotic resistance profiles in the 111 
pathogen population.  112 
S. aureus has an extraordinary capacity of acquiring new resistance traits by the integration into its 113 
genome of exogenous genetic material via horizontal gene transfer and mutational events [26, 27]. In 114 
Staphylococcus spp, the major targets underlying mechanisms of resistance are the cell envelope, the 115 
ribosome and nucleic acids [28]. However, several studies have identified hypothetical proteins as 116 
also being associated with drug resistance specifically in S. aureus [29]. 117 
Characterising the proteins, alone or in combination, that contribute to resistance, can potentially lead 118 
to improved diagnostic tools and therapeutics against antibiotic-resistant S. aureus and may hold the 119 
key to unlocking this global health problem. In veterinary medicine, the identification of multidrug-120 
resistant (MDR) pathogens and the identification of their antibiotic resistance profiles is done by 121 
conventional methods such as disk diffusion, epsilometer test, Vitek, macrodilution and microdilution 122 
[30]. However, such diagnostic tools are not affordable and quick enough to offer real-time control of 123 
invasive infections.  124 
Matrix-Assisted Laser Desorption/Ionisation – Time of Flight Mass Spectrometry (MALDI-TOF) has 125 
been an alternative way of detecting antibiotic resistance thanks to its low-cost and speed [31]. 126 
Antibiotic resistance profiles of several organisms could be determined by MALDI-TOF [32-34], and, 127 
in combination with machine learning techniques, larger datasets, a wide range of microbial species 128 
identification and complex antimicrobial resistance profile could be analysed faster and more easily 129 
and economically, revolutionizing the field of microbiology [35]. S. aureus was one of the most 130 
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frequently studied genera for antimicrobial resistance prediction [36-40]. Rapid and accurate 131 
classification of MRSA and methicillin-sensitive S. aureus (MSSA) based on MALDI-TOF spectral 132 
of clinical samples were obtained by several studies [36, 38, 39]. Analogously, high accuracy results 133 
have been obtained when applying machine learning approaches to MALDI-TOF spectral data for the 134 
prediction of the broad-spectrum antibiotic vancomycin. In particular, successful separation of 135 
vancomycin-intermediate (VISA) from vancomycin-susceptible S. aureus (VSSA) on the basis of 136 
MALDI-TOF data collected from clinical samples [37, 40, 41]. Recently, van Oosten and Klein [42], 137 
developed classification models for S. aureus which assign the mechanisms of action of antibacterial 138 
drugs.  139 
The objective of this study was to find a fast and more accurate alternative to standard susceptibility 140 
tests, to profile multidrug and benzylpenicillin resistance in S. aureus isolates. To this end, we tested 141 
the discriminatory power given by the combination of supervised machine learning and MALDI-TOF, 142 
complemented by a protein-protein interaction (PPI) network and a protein structural analysis 143 
workflow. Here for the first time, we demonstrate that this approach can be used to develop diagnostic 144 
solutions that can discriminate with high performance between benzylpenicillin- and multidrug-145 
resistant and susceptible bovine mastitis-causing S. aureus isolates. 146 
 147 
Results 148 
Sample Analysis 149 
In this study, 82 S. aureus isolates had been cultured from milk samples collected between March 150 
2004 and May 2005. The samples were from 24 herds each in a different farm (24 farms) where 23 151 
farms were in England (most of them in the south) and one farm was in Wales (Llangathen, 152 
Carmarthen). The locations of the farms and S. aureus isolates collected from each farm are shown in 153 
Figure 1 and the breakdown of isolates per farm is shown on Supplementary Table 1. Moreover, 154 
Supplementary Table 2 indicates the antimicrobial susceptibility profile of the resistant isolates that 155 
were obtained from the same animal. 156 
VITEK analysis showed that the cohort consisted of 31 benzylpenicillin-resistant and 51 157 
benzylpenicillin-susceptible isolates. Amongst the resistant isolates, 16 isolates were found to be only 158 
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penicillin-resistant, while 15 isolates had resistance to multiple antibiotics, among these 15 isolates 13 159 
were found to be resistant to three or more antibiotics, with at least one antimicrobial agent in three 160 
antimicrobial classes (multidrug-resistant, MDR), while two isolates were resistant to two or more 161 
antibiotics with at least one antimicrobial agent in two antimicrobial classes (extensively drug-162 
resistant, XDR). We considered the MDR and XDR as one class and named it as MDR for simplicity. 163 
As shown in Figure 2, out of 15 multidrug-resistant isolates, 11 isolates were resistant to 164 
benzylpenicillin, clindamycin, erythromycin, tilmicosin and tylosin; 1 isolate was resistant to 165 
benzylpenicillin, clindamycin, tilmicosin and tylosin; 1 isolate was resistant to benzylpenicillin, 166 
tetracycline and tilmicosin; 1 isolate was resistant to benzylpenicillin and tetracycline, and 1 isolate 167 
was resistant to benzylpenicillin, cefalotin, cefoxitin and oxacillin. 51 isolates were found to be 168 
susceptible to all antibiotics used in this study which were benzylpenicillin, cefoxitin, oxacillin, 169 
cefalotin, ceftiofur, cefquinome, amikacin, gentamicin, kanamycin, neomycin, enrofloxacin, 170 
clindamycin, erythromycin, tilmicosin, tylosin, tetracycline, florfenicol and 171 
trimethoprim/sulfamethoxazole. 172 
 173 
Generation of MALDI-TOF peak lists and set-up of the classifiers 174 
A total of 312 MALDI-TOF raw data spectra had been obtained from 82 S. aureus isolates, on 175 
average 4 replicate spectra per isolate. The peak lists, i.e. the lists of paired mass/charge (m/z) ratios 176 
and corresponding intensity values, were extracted from the raw spectra as specified in the Methods 177 
Section. 178 
Supervised machine learning algorithms were used to implement classifiers to verify if the MALDI-179 
TOF peaks associated with isolates could be used to predict their resistance or susceptibility to 180 
benzylpenicillin and multidrug. Being based on supervised learning, all methods required the 181 
availability of training datasets for model building and validation datasets for assessing the 182 
performance of the classifier. The prediction performance of each classifier was evaluated measuring 183 
accuracy, sensitivity, specificity and kappa. Thirty iterations of nested cross-validation (described in 184 
Methods) were used to train each classifier. 185 
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The following classification methods, available in the scikit-learn library in Python, were tested: naïve 186 
Bayes, linear and non-linear (RBF kernel) support vector machines (SVM), decision tree, random 187 
forests, multi-layer perceptron neural networks (MLP), AdaBoost (AdaBoost-SAMME version), 188 
logistic regression, linear discriminant analysis (LDA) and quadratic discriminant analysis (QDA). 189 
 190 
Analysis of multidrug-resistant vs susceptible isolates 191 
We first focused on investigating the possibility to develop a classifier to verify if MALDI-TOF peak 192 
lists associated with isolates could be used to predict their multidrug phenotype. Specifically, we 193 
considered the spectra of 15 multidrug-resistant isolates (13 MDR and 2 XDR) and 51 susceptible 194 
isolates (susceptible to all antibiotics tested in this study). A total of 249 raw spectra were analysed. 195 
The pre-processing led to the identification of four different peaks (Table 1) found to appear in at 196 
least 30% of all number of spectra. Due to the unbalanced nature of this specific data set (76% of 197 
samples were susceptible and only 24% were resistant), we first standardised the four features by a 198 
down-sampling method to build robust classifiers [43]. At each one of the 30 runs, 15 samples were 199 
randomly chosen out of the initial 51 susceptible samples and a final balanced (50% resistant, 50% 200 
susceptible) dataset was generated. The four peaks were then used as features to build ten classifiers 201 
and to develop predictive models for the multidrug phenotype. Before the classification, features were 202 
standardised (mean centred and unit variance) then resistant and susceptible isolates were labelled as 203 
0 and 1, respectively. 30 runs using nested cross-validation were performed. Amongst the investigated 204 
machine learning approaches, LDA, linear SVM and RBF SVM were found as the top three best 205 
performance showing algorithms, respectively. Diagnostic systems trained on individual isolates 206 
coming from 24 different farms achieved up to (mean result ± standard deviation over 30 runs on the 207 
test set): accuracy = 96.81% ±0.43 %, sensitivity = 99.88% ± 0.41%, specificity = 95.96% ± 0.52%, 208 
and kappa = 91.83% ± 1.37% in LDA algorithm. Detailed performance results of all classifiers on test 209 
data can be found in Figure 3.  210 
 211 
Table 1. Statistical evaluation of the 4 peaks with an overall frequency of appearance higher 212 




PTTA PWKW Ave1 Ave2 StdDev1 StdDev2 PA PA1 PA2 
4.807 3.78E-12 1.34E-07 7.27 19.55 5.89 3.72 66.88 35.71 98.04 
6.422 0.00036 0.041891 6.92 10.30 4.54 2.00 45.31 35.71 54.90 
6.891 0.02021 0.12752 31.98 43.04 23.96 14.89 80.18 64.29 96.07 
9.621 6.81E-08 3.73E-07 32.39 43.00 3.28 6.23 100.00 100.00 100.00 
 214 
PTTA is the p-value of Welch‘s t-test; PKWK is the p-value of Wilcoxon test; index 1 refers to resistant isolates; index 215 
2 refers to susceptible isolates; Ave is the overall intensity average; Ave1 is the intensity average of class ’Resistant’; 216 
Ave2 is the intensity average of class ’Susceptible’; StdDev is the overall intensity standard deviation; StdDev1 is the 217 
intensity standard deviation of class ’Resistant’; StdDev2 is the intensity standard deviation of class ’Susceptible’; PA 218 
is the overall proportion of appearance; PA1 is the proportion of appearance of class ’Resistant’; PA2 is the proportion 219 
of appearance of class ’Susceptible’. 220 
 221 
Analysis of benzylpenicillin-resistant only vs susceptible isolates 222 
Next, we investigated resistance and susceptibility to benzylpenicillin only. This was to isolate 223 
specific patterns underlying resistance to this specific antibiotic. We chose benzylpenicillin because it 224 
was the only antibiotic for which we had singly resistant isolates. 225 
To this aim, the spectra of the 16 benzylpenicillin-resistant only isolates and 51 susceptible isolates 226 
(susceptible to all antibiotics tested in this study) were first pre-processed as described in the Methods 227 
Section. Five peaks were found in at least 30% of the overall number of spectra (Table 2). Due to the 228 
unbalanced nature of this specific data set (76% of samples are susceptible and only 24% are 229 
resistant), we first standardised the five features by a down-sampling method to build robust 230 
classifiers [43]. At each one of the 30 runs, 16 samples were randomly chosen out of the initial 51 231 
susceptible samples and a final balanced (50% resistant, 50% susceptible) dataset was generated. The 232 
five peaks were then used as features to build ten classifiers and to develop predictive models for the 233 
benzylpenicillin phenotype. Before the classification, features were standardised (mean centred and 234 
unit variance) then resistant and susceptible isolates were labelled as 0 and 1, respectively. 30 runs 235 
using nested cross-validation was performed. Amongst the investigated machine learning approaches 236 
RBF SVM, neural network and logistic regression were those that achieved the best performance. 237 
Diagnostic systems trained on individual isolates coming from 24 different farms achieved up to 238 
(mean result ± standard deviation over 30 runs on the test set); accuracy = 97.54% ± 1.91%, 239 
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sensitivity = 99.93% ± 0.25%, specificity = 95.04% ± 3.83%, and kappa = 95.04% ± 3.83% in RBF 240 
SVM algorithm. Detailed performance results of all classifiers on test data can be found in Figure 4. 241 
Notably, four peaks (4.807kDa, 6.422kDa, 6.891kDa and 9.621kDa) were found common in the 242 
analysis of benzylpenicillin-resistant vs susceptible and multidrug-resistant vs susceptible isolates. 243 
When comparing the intensities of these four peaks in the two datasets (resistant vs. susceptible) we 244 
observed that 4.807kDa, 6.891kDa and 9.621kDa had a higher average in susceptible isolates 245 
consistently while 6.422kDa had a higher average of intensity in benzylpenicillin-resistant only 246 
isolates class. 4.305kDa which was specific to benzylpenicillin-resistant only analysis had higher 247 
average intensity in resistant than susceptible isolates. 248 
 249 
Table 2. Statistical evaluation of the 5 peaks with an overall frequency of appearance higher than 250 
30% based on the benzylpenicillin resistant only vs susceptible data set. 251 
Mass 
(kDa) 
PTTA PWKW Ave1 Ave2 StdDev1 StdDev2 PA PA1 PA2 
4.305 0.258564 0.213998 10.20 9.34 2.60 2.64 34.33 37.50 33.33 
4.807 7.02E-08 5.96E-07 12.94 19.55 4.02 3.72 92.54 75.00 98.04 
6.422 0.39999 0.50342 10.81 10.30 2.44 2.00 58.21 68.75 54.90 
6.891 5.69E-12 8.31E-08 10.00 43.04 8.80 14.89 76.12 56.16 96.07 
9.621 1.81E-10 3.35E-08 29.84 43.00 5.54 6.23 100.00 100.00 100.00 
 252 
PTTA is the p-value of Welch‘s t-test; PKWK is the p-value of Wilcoxon test; index 1 refers to resistant isolates; index 253 
2 refers to susceptible isolates; Ave is the overall intensity average; Ave1 is the intensity average of class ’Resistant’; 254 
Ave2 is the intensity average of class ’Susceptible’; StdDev is the overall intensity standard deviation; StdDev1 is the 255 
intensity standard deviation of class ’Resistant’; StdDev2 is the intensity standard deviation of class ’Susceptible’; PA 256 
is the overall proportion of appearance; PA1 is the proportion of appearance of class ’Resistant’; PA2 is the proportion 257 
of appearance of class ’Susceptible’. 258 
 259 
Machine learning analyses undertaken to prove the effectiveness of our method to differentiate 260 
susceptibility/resistance profiles rather than strain differences   261 
Because two of the five discriminant proteins found in this work were of ribosomal origins and 262 
ribosomal proteins have been used for the discrimination of major S. aureus lineages based on 263 
MALDI-TOF analysis [44-47], we performed further analyses in support that our classifiers were 264 
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picking up susceptibility/resistance differences  rather than strain differences. First, we investigated if 265 
and how in the sole presence of the ribosomal peaks as input features or in their absence the 266 
performance of the classifiers changed and how.  As shown in Supplementary Table 3 by removing 267 
only the ribosomal proteins from the analysis of both multidrug and benzyl-penicillin datasets, the 268 
performance of the classifiers decreases but not significantly, all indicators are still above 80%. 269 
However, when using only the ribosomal proteins as input features for the analysis of both multidrug 270 
and benzyl-penicillin datasets, the specificity and Cohen’s kappa indicators drop to unacceptable 271 
values for both the multidrug and benzyl-penicillin predicted phenotypes. Altogether these results 272 
indicate that the ribosomal proteins in combination with the other discriminant proteins are 273 
contributing to the susceptibility/resistance classification but do not play a major role in the 274 
classification.  275 
 276 
Biomarker Characterization – Identification of the proteins found to correspond to the MALDI-277 
TOF spectral peaks recognised as discriminant by the trained classifiers 278 
The five peaks identified as providing optimal discrimination between benzylpenicillin-resistant only 279 
and susceptible isolates were further analysed to identify their correspondent S. aureus proteins. It 280 
should be noted that the four peaks identified as providing optimal discrimination between multidrug-281 
resistant and susceptible were also amongst these peaks. When compared to the reference S. aureus 282 
Newbould 305 (ATCC 29740) proteome, the five peak masses identified the following five S. aureus 283 
proteins: two hypothetical proteins (molecular weights of 4801.95 and 6901.37 Da), RpmJ, RpmD 284 
and DNA-binding protein HU. The molecular weights of the corresponding proteins changed slightly 285 
from those in the original spectra as a result of the search criteria outlined in the Methods (Table 3). In 286 
order to better understand the functions and roles of these proteins within the drug resistance 287 
phenotype, we characterised the molecular functions (MF), cellular components (CC), and biological 288 
processes (BP) they may carry out. RpmJ and RpmD are the 50S ribosomal proteins L36 and L30, 289 
respectively. HU is a histone-like DNA-binding protein, which interacts with DNA to protect from 290 
denaturation [48]. For the hypothetical proteins, we used 3D threading methods to predict the Gene 291 
Ontology (GO) functions (Figure 5). The hypothetical protein of 4801.95Da was annotated as COPII-292 
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coated vesicle cargo loading (BP), intracellular protein transport (BP), proteolysis (BP), homophilic 293 
cell adhesion via plasma membrane adhesion molecules (BP) and ion binding (MF). The hypothetical 294 
protein of 6901.37Da was annotated as being involved with the small molecule metabolic process 295 
(BP), antibiotic metabolic process (BP), lipid transport (BP) and ion binding (MF). 296 
With the aim to further characterise the function of these proteins we did a PSI-BLAST comparative 297 
analysis; all discriminant proteins with 100% coverage and significant e-values are shown in Table 3. 298 
Next, we investigated the drug resistance interactome by building the protein-protein interaction 299 
network. The benzylpenicillin PPI network, including the four significant proteins (RpmJ, RpmD, HU 300 
and HP2) and their 149 first neighbours, was generated (Figure 6). It should be noted that HP1 could 301 
not be found in the S. aureus proteome that was available in STRING database. GO and KEGG 302 
analyses of the network showed enrichment for ribosome, nucleic acid binding and catalytic activity 303 
(Figure 7). 304 
Tetracycline resistance protein (TetM) and elongation factor G (FusA) were found as the first 305 
neighbours of RpmJ and RpmD based on the experimental findings of their homologs in E. coli [49, 306 
50]. Additional four proteins (MecA, BlaZ, PbpA and metallo-beta-lactamase (MBL)) were 307 
associated with beta-lactams, rRNA adenine N-6-methyltransferase (ErmA), macrolides resistance, 308 
multidrug efflux pump (NorA) and ABC transporter protein (ABC-2). These proteins were found to 309 
interact with some first neighbours of the discriminant proteins in the network. Penicillin-binding 310 
protein 2 prime (MecA) was shown to share a common interactor, cell division protein (DivIB), with 311 
the discriminant protein RpmD. The interactions of MecA-DivIB (interaction score: 0.639) and 312 
DivIB-RpmD (interaction score: 0.864) are based on experimental/biological data coming from 313 
homologs in other species [51]. MecA was also shown to share a common interactor, DNA 314 
polymerase I (PolA), with the discriminant protein HU. While the interaction of MecA-PolA was 315 
based on text mining (interaction score: 0.432), the interaction of PolA-HU was based on 316 
experimental/biological data (interaction score: 0.668) obtained from homologs in other species [52, 317 
53]. PolA was the only protein which links (based on text mining) HU to other beta-lactam resistance 318 
proteins such as penicillin-binding protein I (PbpA) (interaction score: 0.499) and beta-lactamase 319 
(BlaZ) (interaction score: 0.425) [52, 54]. PbpA was also shown to share the common interactor 320 
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DivIB with discriminant proteins RpmD and RpmJ. ErmA was shown to share common nodes 321 
(ribosomal proteins) with the discriminant proteins RpmD and RpmJ. ErmA was shown, based on text 322 
mining, to also interact with PolA, linked to HU as previously described, (interaction score: 0.611) 323 
[55] and to other proteins (RpsA, MetG and GuaA), based on co-expression, gene fusion and co-324 
occurrence (interaction scores >0.400). NorA was shown to share a common interactor, DNA 325 
topoisomerase (TopA) with the discriminant protein HU. ABC-2 was shown to share common 326 
interactors, signal recognition particle proteins FfH and FtsY with discriminant proteins RpmD and 327 
RpmJ. MBL was shown to share a common interactor, putative fatty oxidation complex protein 328 
(AID38649.1), with discriminant protein RpmJ based on co-expression, gene fusion and co-329 
occurrence (interaction scores > 0.400). 330 
Notably, the PPI analysis of the benzylpenicillin-resistant proteome, 153 proteins – a total of 4 331 
discriminant proteins and 149 first neighbour proteins – showed higher connectivity (clustering 332 
coefficient 0.728) than the complete S. aureus proteome network (clustering coefficient 0.421). The 333 
average number of neighbours per protein was 68.719 in the benzylpenicillin-resistant proteome 334 
network and 27.190 in the complete S. aureus proteome network. In terms of network density, the 335 
values ranged between 0.452 (benzylpenicillin-resistant proteome network) and 0.009 (complete S. 336 
aureus proteome network) and for the network heterogeneity the values ranged between 0.528 337 
benzylpenicillin-resistant proteome network) and 1.243 (complete S. aureus proteome network). 338 
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Table 3. Annotation of the S. aureus proteins corresponding to the five MALDI-TOF peaks recognized as significant by the trained classifiers: peak 339 
mass charge ratio, predictedprotein mass, top PSI-BLAST matches, conserved domain analyses, cellular locations and overexpressed classes are shown.    340 
 341 
HP: hypothetical protein. Column 1 shows the mass charge ratio of the MALDI-TOF peaks identified by the machine learning framework; column 2 shows the predicted molecular weights of 342 
the proteins corresponding to the MALDI-TOF peaks; column 3 shows best PSI-BLAST matches; column 4 shows the identities and e-values obtained with the PSI-BLAST matches; column 343 
5 shows the domain and e-value predicted with CDD database; column 6 shows the results obtained with the PSORTB predictor; and column 7 shows the overexpressed class where the 344 
corresponding proteins have the highest intensity.345 
MALDI-
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Discussion 346 
Antibiotic-resistant S. aureus infections are a major concern in human and veterinary medicine. 347 
Recently, dairy cattle have been shown to be an important risk factor for zoonotic transfer [1]. Fast, 348 
affordable and effective diagnostic solutions which are able to detect the specific S. aureus strains and 349 
their antibiotic resistance and susceptibility profiles are key to support effective and targeted 350 
treatment selection.  351 
Motivated by identifying the most effective method to discriminate (MDR- and benzylpenicillin-) 352 
resistant and susceptible S. aureus strains, we approached the task in a principled way by applying 353 
optimization techniques to overcome uncertainty in data features and by using a wide repertoire of 354 
classification methods. In general, most of the classifiers tested achieved high performance and had 355 
kappa values over 85.00%. However, amongst the investigated machine learning approaches RBF 356 
SVM, neural network and logistic regression were those that achieved the best performance. 357 
Diagnostic systems trained on individual isolates coming from 24 different farms achieved up to 358 
(mean result ± standard deviation over 30 runs on the test set): accuracy = 97.54% ± 1.91%, 359 
sensitivity = 99.93% ± 0.25%, specificity = 95.04% ± 3.83%, and kappa = 95.04% ± 3.83% in RBF 360 
SVM algorithm. We showed that our classification methods while offering high out-of-sample 361 
accuracy can also be solved in practical computational times. 362 
While our primary aim was to develop machine learning-powered diagnostics discriminating 363 
benzylpenicillin-resistant and susceptible isolates of bovine mastitis-causing S. aureus, we also 364 
characterized the molecular determinants and interactions underlying the identified antibiotic 365 
resistance and susceptible patterns. Several isolates were obtained from the same animal, some of 366 
them also presented the same antimicrobial susceptibility profile, possibly suggesting that they 367 
represent the same strain. Moreover, none of the S. aureus isolates, except one, were found resistant 368 
to cefoxitin or oxacillin, despite being resistant to penicillin, suggesting that penicillin-resistant S. 369 
aureus isolates in this study were maybe indeed producers of penicillinase instead of being MRSA. 370 
This might be related to the fact that since the first report of S. aureus resistant to methicillin detected 371 
in a dairy herd in the United Kingdom [12] and from the first isolation in 2012, of both mecA and 372 
mecC LA-MRSA in bulk milk from dairy cattle in the UK [17], frequency of detection of mecA and 373 
 16 
mecC LA-MRSA in the UK, gathered from surveillance and large-scale dairy cattle studies, [11, 17] 374 
remained low [15]. The low frequency of resistance to cefoxitin or oxacillin found in our cohort is 375 
possibly reflecting that LA-MRSA is present in the UK, possibly at a low prevalence level. 376 
Our findings showed that the five MALDI-TOF peaks recognized as significant by the trained 377 
classifiers were found to correspond to two ribosomal proteins (RpmJ and RpmD), DNA-binding HU 378 
protein and two hypothetical proteins. RpmD, DNA-binding HU protein and two hypothetical 379 
proteins were also found to give the best discrimination between multidrug-resistant and susceptible 380 
profiles of S. aureus.  381 
The notion that components of the ribosome are important in the growth rate and antibiotic resistance 382 
of bacteria is a well-known concept [56]. Among those determinants involved in intrinsic resistance, 383 
ribosomal proteins have been found to deal with the general response to stress [57]. Similarly, recent 384 
findings highlighted the existence of ribosomal mutations conferring resistance to antibiotics of 385 
several classes not targeting the ribosome [56]. Specifically, it has been shown that ribosomal 386 
mutations can contribute to the evolution of multidrug-resistant profiles, by inducing ribosomal mis-387 
assembly, that in turn leads to a systematic transcriptional cell alteration, ultimately impacting 388 
resistance to multiple antibiotics by interfering with different cellular pathways [56]. RpmJ was 389 
shown to be up-regulated in Pseudomonas aeruginosa when treated with ciprofloxacin and 390 
fluoroquinolone [58] and similarly in S. epidermidis [59]. Moreover, rpmJ was shown to confer 391 
intrinsic multidrug resistance to a varied set of antibiotics (nitrofurantoin, sulfamethoxazole, 392 
rifampicin, tetracycline, vancomycin, ampicillin, colistin, erythromycin) in E. coli, where deletion of 393 
this gene caused the bacteria to become more sensitive than wild type [60]. In comparison, fewer 394 
literature works have been published about rpmD and antibiotic resistance. Sharma-Kuinekel and 395 
collaborators showed that rpmD was downregulated in S. aureus strains which had the antibiotic 396 
tolerance related LytSR system silenced [61]. 397 
The discriminant protein DNA-binding HU protein was found essential in the bacterial survival and 398 
growth of S. aureus [62]. It was also previously found to be correlated to antibiotic resistance by 399 
being upregulated in the mutant S. aureus isolates with silenced serine/threonine kinase PknB, which 400 
also has a penicillin-binding domain [63]. Besides the proteins with known functions, we also 401 
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identified two hypothetical proteins, but we were unable to find any evidence so far linking them to 402 
antibiotic resistance. Although it was not possible for us to identify the function of these hypothetical 403 
proteins, by applying PSI-BLAST and PSORTb v3.0 together with 3D threading modelling searches, 404 
the hypothetical proteins are predicted to be involved in pathways such as antibiotic metabolic 405 
process, lipid/protein transport and ion binding.  406 
Although the elected mechanism to acquire resistance in S. aureus is through horizontal gene transfer, 407 
spontaneous mutations in the core genome and positive selection are also mechanisms used by the 408 
bacteria to acquire several resistances (e.g., fluoroquinolones, linezolid and daptomycin) [27]. The 409 
spontaneous mutation mechanisms involving ribosomal proteins in S. aureus has been previously 410 
found to raise antibiotic resistance (e.g. vancomycin) [64]. Future efforts may integrate genome 411 
sequencing analysis of the isolated strains towards elucidating and understanding the mechanisms 412 
underlying the antibiotic resistance. 413 
We were not surprised that known genes such as blaZ, mecA, pbpA, conferring resistance to penicillin 414 
in S. aureus were not amongst the MALDI-TOF peaks recognized as significant by the trained 415 
classifiers. This is because the mass range resolution of the MALDI-TOF was set to be between 2kDa 416 
and 12kDa, and the BlaZ, MecA, PbpA are all proteins with molecular weights higher than 20kDa. 417 
However, our PPI cluster analysis results showed that these proteins known to confer resistance have 418 
all been found to interact with most of the proteins corresponding to the MALDI-TOF peaks and to 419 
form a highly connected benzylpenicillin proteome network. 420 
While our approach successfully developed a diagnostic solution to identify antibiotic-resistant 421 
signatures, there are limitations to our method which future work may build upon. For one, the 422 
working range of 2-12kDa does not give the possibility to study the complete S. aureus proteome in 423 
relation to a specific phenotype. .  424 
The MDR and XDR isolates, collectively named multidrug-resistant isolates, used in this study were 425 
all resistant to benzylpenicillin in addition to other antimicrobial agents. Therefore, there is a bias 426 
towards peaks determining resistance or susceptibility to benzylpenicillin, which may explain why all 427 
4 multidrug discriminant peaks occurred within the set of benzylpenicillin-only discriminant peaks.  428 
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In this work, we have opted to pre-process all the data together as previously done by several studies 429 
[42, 65-68] instead of splitting it into a training and validation sets for several reasons. First, given the 430 
low number of samples in each of the two minority classes (multidrug resistant and benzylpenicillin-431 
only resistant) it would have been not possible to have a sufficient number of observations in each set 432 
and each partition being enough representative to yield a good peak selection. Moreover, because 433 
some of the peaks appeared in just a subset of these samples (minority classes), the random sampling 434 
of the data performed could increase the chances of getting spurious peaks in the training set that 435 
would not represent the whole minority class. To avoid these problems, we pre-processed all the data 436 
together. 437 
Moreover, this study has been confined to a relatively small number of isolates. Ideally, a larger 438 
number of isolates would have allowed to refine the machine learning predictions. However, other 439 
studies attempted the analysis of antimicrobial resistance on S. aureus with MALDI-TOF and 440 
machine learning and similar sample size. For example, Tang et al. [39], to implement heterogenous 441 
VISA (hVISA) detection models, examined 10 MSSA and 10 MRSA clinical isolates recovered from 442 
individual patients. Wang et al. [40], used MALDI-TOF mass spectra obtained from 35 hVISA/ VISA 443 
and 90 VSSA isolates. Mather et al. [37], tested 21 VISA, 21 hVISA, and 38 VSSA isolates to 444 
develop their SVM based models. Usually, the larger the dataset the greater is the statistical power for 445 
pattern recognition. However, in our machine learning approach, we have used the Nested CV 446 
approach which is known to produce robust and unbiased performance estimates regardless of sample 447 
size [69]. The machine learning performance indicators associated with our models are high 448 
suggesting that models were sufficiently trained.  449 
In addition, we acknowledge, as a limitation of this study, that our data were collected from farms 450 
only in England and Wales. However, this should not pose a restriction on our method’s ability to 451 
predict resistance or susceptibility in other farms across the globe. If it is given a sufficiently diverse 452 
distribution of data to train the supervised learning algorithms, this would reduce any geographical 453 
bias that could affect predictive capability. This study should be considered a proof-of-principle 454 
where we conducted a feasibility work to invest on with larger samples and geographical areas.  455 
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Finally, the downside of requiring larger sample sizes is limitations in data availability, often 456 
requiring reliance on public databases and thus compromise on the type of available data and possible 457 
studies. Unfortunately, in omics and other technology-based data collection analysis, very often only 458 
small samples are available, this is because of limited in vivo experiments, protocols, involvement of 459 
human participants and costs. For example, whilst not being able to rely on large amounts of data, we 460 
had the unprecedented possibility to demonstrate that our methodology is associated with high 461 
classification accuracy even when using small sample size, this applicability may facilitate research 462 
scenarios where only limited data is available. 463 
In addition to the machine learning analyses undertaken to prove the effectiveness of our method to 464 
differentiate susceptibility/resistance profiles rather than strain differences, we also compared the 465 
MALDI-TOF spectral peaks spectral peaks (4305.59Da, 4807.21Da, 6422.3Da, 6891.17Da and 466 
9621.26Da) recognised  as discriminant by our trained classifiers with the peaks previously found in 467 
literature to discriminate the main clonal lineages of S. aureus [41, 44-47]. When we compared our 468 
peaks with those found by Wolters et al. [45], Böhme et al. [46] and Camoez et al. [47], no common 469 
peaks were found between the studies. However, similarities were found between our results and the 470 
findings reported by Josten et al. [44] and Lasch et al. [70]. 471 
In particular, the peaks at m/z 4305.59 (RpmJ), 6422.37 (RpmD), 6891.17 (HP2) and 9621.26 (DNA 472 
binding protein HU) were revealed to be in common between our study and Josten et al. [44]. 473 
However, the variant (m/z 6397) of the ribosomal protein RpmD found by Josten et al. [44] to be 474 
discriminant for the subgroup of CC22 strains was not present in our spectra as we only detected the 475 
peak at m/z 6422.37 corresponding to RpmD. Moreover, although the protein RpmD was considered a 476 
biomarker by Josten et al. [44], it only showed a limited sensitivity (0.167), reflecting a low level of 477 
conservation of the mutations in the clonal lineages. For example, the CC22 biomarker was not 478 
conserved in all spa types of this clonal complex [44]. The peaks m/z 4305.59 (4306 in Josten et al. 479 
[44]), 6891 (6889 in Josten et al. [44]) and 9621.26 (9627 in Josten et al. [44]) although identified in 480 
the S. aureus spectra by Josten et al. [44] were not included in the list of markers distinguishing the 481 
different strains. Moreover, Lasch et al. [70] analysed 59 diverse S. aureus isolates from 6 different 482 
lineages using MALDI-TOF mass spectrometry. Based on their results over a gel view representation 483 
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and a hierarchical cluster analysis, the authors indicated that, with a few exceptions, CC-specific 484 
biomarkers for S. aureus are an exception rather than a rule. The authors found 3 regions that could be 485 
considered biomarkers for some lineages: m/z 3875 and 3891 (CC5); m/z 6552 and 6592 (CC8); m/z 486 
5002 and 5032 (CC22). Therefore, none of the peaks used in our study were considered biomarkers 487 
by Lasch et al. [70]. The results found by Lasch et al. [70] clearly suggests that typing S. aureus can 488 
be rather unsuccessful due to a lack of stable biomarkers to distinct clonal groups, a low classification 489 
accuracy based on different CC types and a cluster analysis that indicate the limited possibilities to 490 
differentiate S. aureus below species levels. 491 
Further comparisons were also made with existing literature coupling MALDI-TOF mass 492 
spectrometry with a refined analysis framework to accurate classify resistant and susceptible S. aureus 493 
strains.  In particular, the peaks (m/z 4305.59, 4807.21, 6422.3, 6891.17 and 9621.26) recognised as 494 
discriminant for the susceptible and resistant profiles in this study with those previously found [36, 495 
39] differentiating MSSA and MRSA recovered from clinical samples or at distinguishing VSSA 496 
from hVISA/VISA [37, 40] no similar peaks were detected under the experimental conditions chosen 497 
here. In particular, our peaks often mapped in the higher and non-overlapping mass range of the 498 
spectrum. Whereas, when we compared our peaks with those found by Asakura et al. [41] to 499 
differentiate VISA, hVISA, and VSSA clinical isolates, we found that one peak (m/z 4306) was in 500 
common between the two studies. This peak is among 23 other peaks that were found to be 501 
statistically significant among VISA, hVISA and VSSA (p < 10−4, Kruskal-Wallis test). This peak 502 
corresponds to the ribosomal protein RpmJ. Indicating that ribosomal proteins can be correlated with 503 
resistance phenotypes. This was also reported by Josten et al. [44] when analysing the peak pattern of 504 
401 MRSA and MSSA strains (see above). 505 
Although we have not typed our strains, which we acknowledge as a limitation of our study, we 506 
believe that it is not unreasonable to assume that we have classified the resistance/susceptibility 507 
phenotype and not the strains. Our supervised learning-based classifier consisted of a binary 508 
classification (resistant/susceptible), where each observation (isolate) was labelled according to the 509 
MIC values obtained for each specific isolate.  Given the high performance indicators accompanying 510 
our classification and given the variety of different peaks among strains as shown by Josten et al. 511 
 21 
[44], Wolters et al. [45], Böhme et al. [46], Camoez et al. [47] and Lasch et al. [70], it is very 512 
unlikely that we could separate all the different strains circulating in just two groups and importantly 513 
with such high performance indicators. From a machine learning point of view, given the limited 514 
number of observations, relative high number of possible strains, binary outcome, number of 515 
genetic/molecular traits different among the strains it would not had been possible to separate the 516 
different strains in just two groups especially with such high-performance scores. This is also in 517 
agreement with Lasch et al. [70] that although performing an elegant modular/hierarchical ANN 518 
analysis of spectra from the S. aureus data set (we only did a one-step machine learning 519 
classification), apart from a fairly good classification accuracy for CC8 strains of S. aureus and, to a 520 
lesser extent for strains of CC5 (80%) and CC30 (78%), the classification accuracy for the other 521 
strains was unacceptably low. Despite intensive efforts aiming at improving these outcomes, neither 522 
variations of the spectral pre-processing nor of the network topology resulted in better classification 523 
results according to the authors. 524 
Overall, we demonstrated that the combination of supervised machine learning and MALDI-TOF 525 
mass spectrometry can be used to develop an effective computational diagnostic solution that can 526 
discriminate between benzylpenicillin/multidrug-resistant and susceptible S. aureus strains. Our 527 
solution could save time and money with respect to traditional susceptibility testing which is not 528 
viable for day-to-day monitoring of antibiotic resistance. Our solution could support farmers with 529 
timely, accurate and targeted treatment selection.  530 
 531 
Methods 532 
Ethics statement 533 
This study received an ethical review and approval from the Clinical Ethical Review panel at the 534 
School of Veterinary Medicine and Science, University of Nottingham (approval Reference number: 535 
2067 170717). All data is owned by QMMS ltd. 536 
 537 
Data Source 538 
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82 S. aureus isolates were collected from 67 animals that were diagnosed with bovine mastitis in 24 539 
different farms, in England and Wales between March 2004 and May 2005. The animals with mastitis 540 
were either primiparous (n=9) or multiparous (n=73, median parity=4). On the day of sample 541 
collection, the days in milk of the cows varied from 1 to 569 days with a median value of 160 days.  542 
 543 
Sample Analysis 544 
Bovine mastitis-causing S. aureus isolates were tested on VITEK 2 AST-GP79 using one Antibiotic 545 
Susceptibility Testing (AST) card per isolate. Each card was filled with at least one positive control 546 
well with no antibiotic and multiple wells with increasing concentrations of antibiotics. We tested 547 
susceptibility to the following antibiotics: benzylpenicillin, cefoxitin, oxacillin, cefalotin, ceftiofur, 548 
cefquinome, amikacin, gentamicin, kanamycin, neomycin, enrofloxacin, clindamycin, erythromycin, 549 
tilmicosin, tylosin, tetracycline, florfenicol and trimethoprim/sulfamethoxazole. Using the VITEK 2 550 
we measured the growth and viability of the isolates in all wells compared to the control wells. 551 
Relative bacterial growth in each antibiotic well was calculated and compared with the positive 552 
control wells. The minimum inhibitory concentration (MIC) values were calculated by comparing the 553 
growth of the bacteria to the growth of isolates with known MICs. The S. aureus isolates were 554 
labelled as either resistant or susceptible according to their antibiotic resistance profiles based on 555 
CLSI breakpoints (VET01-S3) [71]. 556 
  557 
Generation of MALDI-TOF Spectra 558 
All S. aureus isolates were stored at -80 °C since their recovery in 2004/5 using a microbead 559 
preservation system (Technical Service Consultants Ltd, Lancashire). Isolates were recovered onto 560 
Blood agar and incubated at 37 °C for 24 hours. If no growth was initially observed the isolates were 561 
sub-cultured another 24 hours. All isolated were sub-cultured on blood agar at 37 °C for 24 hours 562 
prior to MALDI-TOF analysis. The same storage and growth conditions were applied to all isolates. 563 
The pure cultures were then analysed using the Time-of-flight (TOF) MALDI mass spectrometer 564 
(Bruker Daltonics, Billerica, MA), Microflex – Flex Control Version 3.4, Bruker Daltonics. The order 565 
of sample analysis was randomised, the Bruker Bacterial Test Standard (BTS) (Bruker Daltonics) was 566 
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used for calibration control on every plate. For each isolate, six technical replicates were generated 567 
from 240 desorption’s per replicate (6 x 40 shots), and protein mass spectra acquired in the range 568 
2000 to 20,000 Da were generated. Spectra were compared visually using Biotyper 3.1 (Bruker 569 
Daltonics) to remove low intensity spectra or spectra with substantial background noise. All the 570 
samples used in this study were further analysed visually on Matlab for insufficient resolution 571 
(defined as a measure to distinguish two peaks of slightly different m/z values [72]), low intensity or 572 
substantial background. However, no samples were discarded for these reasons. The. Technical 573 
replicates were further compared using composite correlation indices (CCI) to remove dissimilar 574 
spectra with CCI < 0.99 [73]. At least three good quality spectra per isolate were required for 575 
inclusion of the isolate in the analysis. Moreover, when three qualifying technical replicates could not 576 
be obtained the sample was re-analysed in order to get at least 3 replicates. All the 82 isolates used in 577 
this study had three good quality technical replicates. 578 
Data Processing 579 
The pre-processing steps of MALDI-TOF mass spectra were performed using MATLAB 580 
Bioinformatics Toolbox Release 2017b, The MathWorks, Inc., Natick, Massachusetts, United States. 581 
Our analysis was done using 82 S. aureus isolates with each sample having 3 to 6 replicates. 582 
The pre-processing followed these 8 steps: 583 
1. Mean Computing: the replicates of each biological isolate were averaged. 584 
2. M/Z Cropping: the mass range was cropped to be between 2kDa and 12kDa. 585 
3. Resampling: the data was up-sampled from 13,740 to 20,000 points. 586 
4. Baseline Correction: for each biological isolate, baseline correction was applied by using a 587 
window of 200 Da with a step size of 200 Da to shift the window. The quantile method (10% value) 588 
was used to find the likely baseline value in every window. Shape-preserving piecewise cubic 589 
interpolation approximation was applied to regress the varying baseline. The regressed baseline was 590 
not smoothed. The resulting baseline was subtracted from the spectrum. 591 
5. Normalisation: the area under the curve (AUC) of every spectrum was normalised to the 592 
median and post-rescaled such that the maximum intensity was 100. 593 
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6. Noise reduction: each sample was denoised using least-squares polynomial with a window of 594 
35 Da and a 2-degree polynomial function. 595 
7. Alignment: to align the spectrograms, a set of reference peaks was required. Specifically, the 596 
peaks were selected if present in at least 30% of all spectra. The 30% threshold was chosen following 597 
the workflow suggested in the ClinProTools software documentation [74]. In addition, the first pre-598 
processing step of our workflow consists of averaging all the 3 or more technical replicates of each 599 
sample. Therefore, after this averaging step we have one spectrum per sample and consequently the 600 
30% threshold used to select the peaks is applied to all samples. By applying the 30% threshold we 601 
are selecting only the peaks that are present and hence relevant across both the resistant and 602 
susceptible classes, as shown in Tables 1 and 2 in the Results section. The alignment was estimated 603 
using the default values of msalign function (Bioinformatics Toolbox). 604 
8. Peak Detection: To retain a reasonable intensity a signal-to-noise ratio threshold was defined 605 
at 10% to discard all peaks below it. Therefore, since the spectra were previously normalised to an 606 
overall maximum intensity of 100, any point below 10 is considered noise. A minimum distance of 607 
20Da between neighbouring peaks was set, i.e., two peaks must be at least 20Da apart to be 608 
considered different. 609 
 610 
Spectral Features  611 
After detecting all the peaks in each spectrum, a peak list report was prepared similarly to 612 
ClinProTools 3.0 [74]. Specifically, the peaks were selected if present in at least 30% of all spectra. 613 
The selected peaks were further pre-processed to have zero mean and unit variance. Such peaks 614 
represented the spectral features used in the classification analysis.  615 
 616 
Classification Methods 617 
The performance of the classifiers, naïve Bayes [75], linear and non-linear (RBF kernel) support 618 
vector machines (SVM) [76], decision tree [77], random forests [78], multi-layer perceptron neural 619 
networks (MLP) [79], AdaBoost (AdaBoost-SAMME version [80]), logistic regression [81], linear 620 
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discriminant analysis (LDA) [82] and quadratic discriminant analysis (QDA) [82], was investigated 621 
using the scikit-learn library in Python [83]. 622 
For the classifiers, the following set of values were employed for the hyper-parameter searches: 623 
- Logistic Regression: inverse of regularization strength C = [0.001, 0.01, 0.1, 1, 10, 100, 624 
1000]. 625 
- Linear SVM: penalty parameter of the hinge loss error C = [0.001, 0.01, 0.1, 1, 10, 100, 626 
1000]. 627 
- Decision tree: maximum depth of tree = [10, 20, 30, 50, 100]. 628 
- Random Forests and Adaboost: Number of estimators = [2, 4, 8, 16, 32, 64]. 629 
- MLP Neural Network: α (L2 penalty parameter) = [0.001, 0.01, 0.1, 1, 10, 100], learning rate 630 
(initial learning rate used to control the step size in updating the weights with adam solver) = 631 
[0.001, 0.01, 0.1, 1] and hidden layer sizes = [10, 20, 40, 100, 200, 300, 400, 500]. 632 
- Non-linear SVM with RBF kernel: γ (RBF kernel coefficient) = [0.0001, 0.001, 0.01, 0.1] and 633 
C (L2 penalty parameter) = [0.001, 0.01, 0.1, 1, 10, 100, 1000]. 634 
- Naive Bayes, LDA and QDA do not have hyper-parameters. 635 
 636 
Prediction Performance 637 
The prediction performance of each classifier was evaluated by considering the following indicators, 638 
assuming P and N as the total number of positive (benzylpenicillin/multidrug-resistant) and negative 639 
(multidrug susceptible) isolates, respectively and using T for true (correct) and F for false (wrong) 640 
predictions: 641 
- Sensitivity (True Positive Rate) = TP / P 642 
- Specificity (True Negative Rate) = TN / N 643 
- Accuracy = (TP+TN)/(P+N) 644 
- Kappa = (po – pe)/(1-pe) where po= (TP+TN)/(P+N) and pe= (P*(TP+FN) + N*(FP+TN)) 645 
/(P+N)2 646 
 647 
Performance Analysis 648 
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Nested Cross-validation (NCV) [84], which is a well-established cross-validation technique was 649 
employed to assess the performance and select the hyper-parameters of the proposed classifiers.  650 
In NCV there is an outer loop split of the data set into test and training sets. For each training set, a grid 651 
search (inner loop) is run, in order to find the best hyper-parameters of the classifier using accuracy as 652 
a performance metric. Then, the test set is used to score the best classifier found in the inner loop. These 653 
scores tell us how well the classifier model generalises, given the best hyper-parameters found in the 654 
inner loop. 655 
Thirty iterations were carried out, wherein each iteration an NCV was employed. The inner loop of 656 
the NCV finds the best hyper-parameters of each classifier (when suited) using a stratified 3-fold 657 
cross-validation; the outer loop measures the accuracy, sensitivity, specificity and kappa using a 5-658 
fold stratified cross-validation, in order to compare all the classifiers [85]. 659 
 660 
Biomarker Characterization – Identification of the protein corresponding to MALDI-TOF 661 
spectral peaks recognised as discriminant by the trained classifiers 662 
A dedicated bioinformatics pipeline was developed to find correspondences between individual peaks 663 
selected by the machine learning-based classifiers and actual proteins of S. aureus. First, amino acid 664 
sequences of the proteins in the S. aureus Newbould 305 (ATCC 29740) proteome, which is 665 
considered the model bovine mastitis strain [86], were retrieved from the PATRIC database in 666 
FASTA format. The molecular weights of the proteins were calculated using the Compute pI/Mw tool 667 
on ExPASy [87]. The proteins were filtered in the range of ± 200Da of the mass of individual peaks. 668 
Then, N-terminal methionine cleavage was predicted using the online prediction tool TermiNator [88] 669 
and the theoretical molecular weights of the proteins were re-calculated using compute pI/Mw tool 670 
according to presence or absence of the initial methionine. Finally, proteins with a maximum of 0.2% 671 
difference in mass to the individual peaks for the successful identification of correspondence were 672 
selected. 673 
To further investigate the function of the identified proteins, we studied protein-protein interactions 674 
(PPI) as previously described [89]. The PPI dataset of S. aureus (strain NCTC 8325/PS 47) was 675 
obtained from the STRING database [90] and nodes (proteins) with interaction scores lower than 676 
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medium confidence level (interaction scores <0.400) were filtered out. The remaining nodes 677 
(proteins) were analysed in Cytoscape 3.7.1 based on the following parameters: the average number 678 
of neighbours, clustering coefficient, network density and network heterogeneity [91-93].  679 
The characterisation of antibiotic-resistant genes of the beta-lactam, macrolide and tetracycline 680 
antibiotic classes in the PPIs, were obtained from ResFinder v3.1 [94] and using them as queries in a 681 
comparative BLAST search against the S. aureus proteome. The functions of the genes in the network 682 
were annotated with Gene Ontology terms (biological process, molecular function and cellular 683 
component) and KEGG pathways. Finally, to gain a more in-depth understanding of the protein 684 
functions, homology and threading 3D models for discriminant proteins were built. 3D homology 685 
modelling was used for the proteins with good quality templates in the Swiss-Model repository [95] 686 
and the models built by using Swiss-PdbViewer [96]. The 3D models of hypothetical proteins were 687 
generated by using the threading technique on I-TASSER, where biological functions were predicted 688 
as well [97]. The 3D Models of all discriminant proteins were visualized and edited in UCSF Chimera 689 
[98]. 690 
Homologs of the discriminant proteins were checked in the NCBI database by position-specific 691 
iterative basic local alignment tool (PSI-BLAST). Functional domains were searched against the CDD 692 
v3.17-52910 PSSMs database. PSORTb v3.0 was used to predict cellular locations of the discriminant 693 
proteins [99]. 694 
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FIGURE CAPTIONS 1034 
 1035 
Figure 1. Location of the enrolled farms in the United Kingdom. The circles represent the location 1036 
of the farms and the size of the circles indicate the number of S. aureus isolates in the farms. The 1037 
highest number of isolates provided by a single farm was 21, while the lowest was 1. The green 1038 
colour represents the susceptible S. aureus isolates while the dark and light blue is for multidrug-1039 
resistant and benzylpenicillin-resistant only S. aureus isolates, respectively. The base layer map of the 1040 
UK can be accessed at https://gadm.org/maps/GBR.html. 1041 
 1042 
Figure 2. UpSet plot comparing the profiles of benzylpenicillin-resistant Staphylococcus aureus 1043 
isolates. The total size of resistant S. aureus isolates is shown on the left bar plot. Antibiotic-resistant 1044 
 36 
profiles of S. aureus isolates are visualized by the bottom plot and the occurrence is represented on 1045 
the top bar plot. 1046 
 1047 
Figure 3. Supervised machine learning prediction of multidrug resistance spectral signature 1048 
profiles. Prediction performance results of different classifiers (logistic regression, linear SVM, RBF 1049 
SVM, MLP neural network, decision tree, random forest, AdaBoost, naïve Bayes, quadratic 1050 
discriminant analysis (QDA) and linear discriminant analysis (LDA)) that were used to classify the 1051 
multidrug resistance profiles are shown on the X-axis. Four performance indicators have been used to 1052 
evaluate the classification: accuracy, kappa, sensitivity and specificity. The scores for each 1053 
performance metric are indicated in the Y-axis. 1054 
 1055 
Figure 4. Supervised machine learning prediction of benzylpenicillin resistance spectral 1056 
signature profiles. Prediction performance results of ten different classifiers (logistic regression, 1057 
linear SVM, RBF SVM, MLP neural network, decision tree, random forest, AdaBoost, naïve Bayes, 1058 
quadratic discriminant analysis (QDA) and linear discriminant analysis (LDA)) that were used to 1059 
classify the benzylpenicillin resistance profiles are shown on the X-axis. Four performance indicators 1060 
have been used to evaluate the classification: accuracy, kappa, sensitivity and specificity. The scores 1061 
for each performance metric are indicated in the Y-axis. 1062 
 1063 
Figure 5. 3D structures of the five proteins found to correspond to the MALDI-TOF spectral 1064 
peaks recognized as discriminant between benzylpenicillin resistant and susceptible isolates. 1065 
Top row from left to right: homology model of ribosomal protein L36p (RpmJ, mw: 4305.36Da), 1066 
threading model of hypothetical protein (HP1, mw: 4801.95Da) and homology model of ribosomal 1067 
protein L30p (RpmD, mw: 6422.48Da). Bottom row from left to right: threading model of 1068 
hypothetical protein (HP2, mw: 6901.37Da) and homology model of bacterial DNA-binding protein 1069 
(HU, mw: 9626.01Da). 1070 
 1071 
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Figure 6. Protein-protein interaction network of the proteins found to correspond to the 1072 
MALDI-TOF spectral peaks recognized as discriminant between benzylpenicillin resistant and 1073 
susceptible isolates. The PPI network showing the four discriminant proteins, green circles, (RpmJ, 1074 
RpmD, HU and hypothetical protein 2 (HP2)) and their first neighbour interactors (orange colours). 1075 
Amongst these first shell interacting partners, purple nodes represent the antibiotic-resistant proteins 1076 
(BlaZ, NorA, MecA, PbpA, ErmA, ABC-2, TetM, FusA and MBL) predicted by ResFinder v3.1 [94].  1077 
 1078 
Figure 7. Functional enrichment analysis of the benzylpenicillin network in Staphylococcus 1079 
aureus based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) 1080 
pathways. The network contains the 4 discriminant proteins, that were found to be discriminant 1081 
between benzylpenicillin resistant and susceptible isolates, and their 149 first neighbours. GO consists 1082 
of cellular component (CC), molecular function (MF) and biological process (BP). In each ontology, 1083 
the enriched categories and the number of genes populating them are shown. Likewise, the enriched 1084 
KEGG pathways and the number of genes populating each pathway are indicated. 1085 
 1086 
Supplementary Table 1. Breakdown of samples per farm 1087 
 1088 
Supplementary Table 2. Antimicrobial susceptibility profile of the resistant isolates that were 1089 
obtained from the same animal 1090 
 1091 
Supplementary Table 3. A) Supervised machine learning prediction of multidrug resistance spectral 1092 
signature profiles using the Linear Discriminant Analysis (LDA) classifier. Prediction performance 1093 
results using all the peaks (4807m/z, 6422m/z, 6891m/z and 9621m/z); only the non-ribosomal peaks 1094 
(4807m/z, 6422m/z, 6891m/z and 9621m/z) and only the ribosomal peak (6422m/z).  B) Supervised 1095 
machine learning prediction of multidrug resistance spectral signature profiles using a non-linear 1096 
(RBF kernel) support vector machine (RBF-SVM) classifier. Prediction performance results using all 1097 
the peaks (4305m/z, 4807m/z, 6422m/z, 6891m/z and 9621m/z); only the non-ribosomal peaks 1098 
(4807m/z, 6422m/z, 6891m/z and 9621m/z) and only the ribosomal peak (4305m/z and 6422m/z).  1099 
 38 
 1100 
